Salem Partners: Funding, Team & Investors | Startup Intros

Loading organizations...

Salem Partners: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jul 9, 2019	Onconano Medicine	$23.7M Series A Extension	John Dyett	—
Apr 1, 2019	Lucid Sight	$6.0M Series B	—	Blockchain Coinvestors AngelList Syndicate, Galaxy Digital, IVP, Pitbull Ventures, Chris M. Willliams, Clark Landry, Animoca Brands, Breakaway Growth Fund, DFJ Frontier, Digital Currency Group, Galaxy Digital, Rana Capital Partners
Nov 13, 2018	AsclepiX Therapeutics	$5.0M Other Equity	Joshua Barer	Piedmont Capital Partners, Kevin Slawin, TEDCO
May 17, 2018	Onconano Medicine	$11.7M Series A	John Dyett	—
Jul 25, 2017	Sebacia	$36.0M Debt / Series D	—	Accuitive Medical Ventures, Domain Associates, Hercules Capital, Mass General Brigham, John Dyett, Versant Ventures
May 1, 2016	Lucid Sight	$4.0M Series A	Rana Capital Partners, Salem Partners	Chris M. Willliams
Apr 30, 2015	Femasys	$10.2M Other Equity	Legacy Capital Partners, Ernest Mario, Salem Partners	—
Mar 1, 2014	ZS Pharma	$55.0M Series D	Novo Holdings	RiverVest, 3x5 Special Opportunity Fund, Adage Capital Management, Alta Partners, Devon Park Bioventures, RA Capital Management, RiverVest Venture Partners, Sofinnova Ventures
Oct 28, 2012	ZS Pharma	$46.0M Other Equity	Robert Alexander	3x5 Special Opportunity Fund, Devon Park Bioventures, John McKearn